Radiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


DOI: 10.1148/radiol.2422052132
This Article
Right arrow Abstract Freely available
Right arrow Figures Only
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bae, K. T.
Right arrow Articles by Hildebolt, C. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bae, K. T.
Right arrow Articles by Hildebolt, C. F.
(Radiology 2007;242:582-589.)
© RSNA, 2007


Thoracic Imaging

Effect of Patient Weight and Scanning Duration on Contrast Enhancement during Pulmonary Multidetector CT Angiography1

Kyongtae T. Bae, MD, PhD, Cheng Tao, MD, Safiye Gürel, MD, Cheng Hong, MD, PhD, Fang Zhu, MD, PhD, Todd A. Gebke, RT, Margherita Milite, PhD and Charles F. Hildebolt, DDS, PhD

1 From the Department of Radiology, University of Pittsburgh, School of Medicine, 200 Lothrop St, Pittsburgh, PA 15213 (K.T.B., C.T., C.H., F.Z.); Mallinckrodt Institute of Radiology, Washington University School of Medicine, St Louis, Mo (T.A.G., C.F.H.); Department of Radiology, Abant Yzzet Baysal University, School of Medicine, Golkoy-Bolu, Turkey (S.G.); and Siemens Medical Systems, Iselin, NJ (M.M.). Received December 27, 2005; revision requested February 22, 2006; revision received March 17; accepted May 2; final version accepted May 5. Address correspondence to K.T.B. (e-mail: baek{at}upmc.edu).


    ABSTRACT
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 ADVANCES IN KNOWLEDGE
 References
 
Purpose: To retrospectively evaluate the amount of contrast medium required with 16- and 64-section computed tomography (CT) for a given patient weight to achieve desirable contrast enhancement during pulmonary CT angiography.

Materials and Methods: Institutional review board approval was obtained, and informed consent was not required for this HIPAA-compliant study. Eighty-five patients (35 men, 50 women; range, 22–87 years) who had undergone 16-section (n = 48) or 64-section (n = 37) CT for the detection of pulmonary embolism were retrospectively evaluated. Contrast medium containing 350 mg of iodine per milliliter was injected at a rate of 4 mL/sec. The injected volume corresponded to the injection rate multiplied by the sum of the scanning delay plus the scanning duration, up to 125 mL. The scanning delay was determined with bolus tracking. Contrast enhancement was measured in the main pulmonary artery and the aorta. For each patient, the injected contrast medium volume per body weight index was calculated. Linear regression analysis was performed, and the Wilcoxon signed rank test was used to assess differences between 16- and 64-section CT.

Results: A range of patient weights (45.3–153.0 kg) and contrast medium volumes (76–125 mL) were noted. The regression formula indicated that 1.2 mL per kilogram body weight of contrast medium was required to achieve 250 HU. The median scanning duration was shorter for 64-section CT than for 16-section CT (5.7 seconds vs 9.5 seconds, P < .001). Consequently, 64-section CT required 17.6% less contrast medium than did 16-section CT (85.4 mL vs 103.6 mL, P < .001). Median contrast enhancement in the pulmonary artery was 8.9% lower with 64-section CT than with 16-section CT (257.7 HU vs 282.9 HU, P = .11).

Conclusion: To achieve consistent contrast enhancement during pulmonary CT angiography, the amount of contrast medium can be adjusted to the patient's body weight.

© RSNA, 2007


    INTRODUCTION
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 ADVANCES IN KNOWLEDGE
 References
 
Pulmonary computed tomographic (CT) angiography is widely used to evaluate patients who are clinically suspected of having pulmonary embolism to either rule out or confirm the diagnosis. Advances in multidetector CT have led to improved spatial resolution, delineation of the peripheral pulmonary arteries, and detection of small emboli, thereby increasing sensitivity and specificity in the diagnosis of pulmonary embolism (1,2). The scanning speed for multidetector CT has also markedly increased, which helps to reduce motion artifacts and improve contrast enhancement and image quality.

Recently introduced 64-section CT allows us to obtain an entire scan of the pulmonary artery within a few seconds. As a result, scan timing becomes far more critical and challenging with 64-section CT scanners than with older and slower CT scanners (35). The other consideration is that the short scanning time of multidetector CT may provide us with an opportunity to improve contrast enhancement and use contrast medium more efficiently. With multidetector CT, the amount of contrast medium injected during some clinical applications may be reduced without decreasing contrast enhancement.

A wide range of contrast medium volumes (80–150 mL) has been reported for pulmonary CT angiography (1,39). Injection rates ranging from 2 to 5 mL/sec have been used. This diversity in contrast material administration protocols is caused in part by the rapid changes and new developments in CT technology. As CT technology evolves, contrast material injection protocols must be adjusted and optimized.

A patient's body weight and the amount of contrast medium injected are closely related to the degree of contrast enhancement (1017). Unlike imaging in the liver and the aorta, this relationship has been infrequently studied for pulmonary CT angiography. In addition, because of its faster scanning speed, 64-section CT would require less contrast medium than 16-section CT to yield equivalent contrast enhancement during pulmonary CT angiography. To our knowledge, this difference in scanning speed, which affects the required amount of contrast medium and the degree of contrast enhancement obtained during pulmonary CT angiography, has not been previously addressed. Thus, the purpose of our study was to retrospectively evaluate the amount of contrast medium required with 16- and 64-section CT for a given patient weight to achieve desirable contrast enhancement during pulmonary CT angiography.


    MATERIALS AND METHODS
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 ADVANCES IN KNOWLEDGE
 References
 
Washington University review board approval was obtained, and informed consent was not required for this retrospective Health Insurance Portability and Accountability Act–compliant study.

Patients
To obtain a list of patients who had undergone chest CT for the detection of pulmonary embolism, one author (C.T.) retrospectively reviewed the CT log books of a 16-section (Sensation 16; Siemens Medical Solutions, Forchheim, Germany) and 64-section (Sensation 64; Siemens Medical Solutions) CT scanner from February to April 2005. We identified 85 consecutive patients in the log books and included 48 patients (22 men, 26 women; mean age, 60 years; range, 24–87 years) who had undergone 16-section CT and 37 patients (13 men, 24 women; mean age, 56 years; range, 22–86 years) who had undergone 64-section CT. The patient's body weight at the time of CT was retrieved from the hospital clinical database by one author (C.T.).

CT Imaging
Our standardized pulmonary embolism scanning protocol consisted of 120 kVp, 130 effective mAs, and 16 x 0.75-mm collimation for 16-section CT and 120 kVp, 150 effective mAs, and 64 x 0.6-mm collimation for 64-section CT. The images were reconstructed with a standard soft-tissue kernel at a section thickness of 1 mm, with no intersection gap.

For both 16- and 64-section CT, contrast enhancement was achieved by injecting ioversol (Optiray 350; Tyco Health/Mallinckrodt, St Louis, Mo), which contains 350 mg of iodine per milliliter, at a rate of 4.0 mL/sec by using a power injector (CT 9000 ADV; Tyco Health/Mallinckrodt). Contrast medium was administered into an antecubital vein through a 20-gauge angiographic catheter. The volume of contrast medium that was injected corresponded to the product of the injection rate multiplied by the sum of the scanning delay plus the scanning duration, up to the maximum volume of 125 mL. Thus, for a scanning delay of 15 seconds and a scanning duration of 10 seconds, the injected volume of contrast medium would be 100 mL (ie, 4 mL/sec multiplied by 25 seconds). In practice, a 125-mL prefilled syringe was loaded into the injector.

When the total scanning time after the start of injection (ie, the sum of the scanning delay plus the scanning duration) was longer than the injection duration for 125 mL of contrast medium (ie, 31.25 seconds), no additional contrast medium was used, and contrast enhancement was based on 125 mL of contrast medium. On the other hand, if scanning ended before the completion of injection, the injection was synchronously terminated by the CT technologists at the end of scanning because contrast medium injected after the completion of scanning has no diagnostic use and is clinically undesirable.

The scanning delay for the diagnostic scan was determined by using a bolus-tracking method. To briefly describe this method, first, a circular region of interest (ROI) measuring 5–10 mm in diameter is placed over the main pulmonary artery (by a CT technologist) after the reference CT image is obtained. As the contrast medium is injected, one technologist stays with the patient in the CT scanning room and checks the integrity of the injection site and confirms the absence of contrast medium extravasation. This technologist then leaves the scanning room, and the first monitoring scan with bolus tracking is obtained about 10 seconds after the start of injection. Contrast enhancement within the ROI is measured on the monitoring scans.

Diagnostic CT scanning is triggered when the measured contrast enhancement exceeds a threshold value of 100 or 125 HU for 16-section CT and 150 HU for 64-section CT (Fig 1). A higher threshold value was used for 64-section CT compared with 16-section CT in an attempt to provide a slightly longer scanning delay. We believed that, with its shorter scanning duration, 64-section CT might need a longer scanning delay to center the scan during maximal contrast enhancement (18,19).


Figure 1A
View larger version (91K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 1a: (a–c) Transverse CT images acquired at the level of the main pulmonary artery and (d, e) bolus-tracking time-enhancement curves; a–d are from one patient scanned with 64-section CT, and e is from a different patient scanned with 16-section CT. Reference image a was obtained prior to contrast medium injection. A circular ROI was placed over the main pulmonary artery to monitor contrast enhancement. Monitoring image b was obtained 10 seconds after contrast medium injection (magnitude of contrast enhancement, 282 HU). In d, the threshold value of 150 HU (arrowhead) and the level of contrast enhancement (282 HU) at 10 seconds are displayed for the first monitoring scan. Diagnostic image c contains ROIs placed over the main pulmonary artery and the ascending and descending aorta. The bolus-trigger threshold level is typically exceeded during the acquisition of the first monitoring scan at 10 seconds. In some patients, the trigger is delayed, probably because of slow circulation or cardiac output. In a patient with cardiac failure (e), it took 22 seconds to reach a threshold value of 125 HU.

 

Figure 1B
View larger version (103K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 1b: (a–c) Transverse CT images acquired at the level of the main pulmonary artery and (d, e) bolus-tracking time-enhancement curves; a–d are from one patient scanned with 64-section CT, and e is from a different patient scanned with 16-section CT. Reference image a was obtained prior to contrast medium injection. A circular ROI was placed over the main pulmonary artery to monitor contrast enhancement. Monitoring image b was obtained 10 seconds after contrast medium injection (magnitude of contrast enhancement, 282 HU). In d, the threshold value of 150 HU (arrowhead) and the level of contrast enhancement (282 HU) at 10 seconds are displayed for the first monitoring scan. Diagnostic image c contains ROIs placed over the main pulmonary artery and the ascending and descending aorta. The bolus-trigger threshold level is typically exceeded during the acquisition of the first monitoring scan at 10 seconds. In some patients, the trigger is delayed, probably because of slow circulation or cardiac output. In a patient with cardiac failure (e), it took 22 seconds to reach a threshold value of 125 HU.

 

Figure 1C
View larger version (71K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 1c: (a–c) Transverse CT images acquired at the level of the main pulmonary artery and (d, e) bolus-tracking time-enhancement curves; a–d are from one patient scanned with 64-section CT, and e is from a different patient scanned with 16-section CT. Reference image a was obtained prior to contrast medium injection. A circular ROI was placed over the main pulmonary artery to monitor contrast enhancement. Monitoring image b was obtained 10 seconds after contrast medium injection (magnitude of contrast enhancement, 282 HU). In d, the threshold value of 150 HU (arrowhead) and the level of contrast enhancement (282 HU) at 10 seconds are displayed for the first monitoring scan. Diagnostic image c contains ROIs placed over the main pulmonary artery and the ascending and descending aorta. The bolus-trigger threshold level is typically exceeded during the acquisition of the first monitoring scan at 10 seconds. In some patients, the trigger is delayed, probably because of slow circulation or cardiac output. In a patient with cardiac failure (e), it took 22 seconds to reach a threshold value of 125 HU.

 

Figure 1D
View larger version (12K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 1d: (a–c) Transverse CT images acquired at the level of the main pulmonary artery and (d, e) bolus-tracking time-enhancement curves; a–d are from one patient scanned with 64-section CT, and e is from a different patient scanned with 16-section CT. Reference image a was obtained prior to contrast medium injection. A circular ROI was placed over the main pulmonary artery to monitor contrast enhancement. Monitoring image b was obtained 10 seconds after contrast medium injection (magnitude of contrast enhancement, 282 HU). In d, the threshold value of 150 HU (arrowhead) and the level of contrast enhancement (282 HU) at 10 seconds are displayed for the first monitoring scan. Diagnostic image c contains ROIs placed over the main pulmonary artery and the ascending and descending aorta. The bolus-trigger threshold level is typically exceeded during the acquisition of the first monitoring scan at 10 seconds. In some patients, the trigger is delayed, probably because of slow circulation or cardiac output. In a patient with cardiac failure (e), it took 22 seconds to reach a threshold value of 125 HU.

 

Figure 1E
View larger version (16K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 1e: (a–c) Transverse CT images acquired at the level of the main pulmonary artery and (d, e) bolus-tracking time-enhancement curves; a–d are from one patient scanned with 64-section CT, and e is from a different patient scanned with 16-section CT. Reference image a was obtained prior to contrast medium injection. A circular ROI was placed over the main pulmonary artery to monitor contrast enhancement. Monitoring image b was obtained 10 seconds after contrast medium injection (magnitude of contrast enhancement, 282 HU). In d, the threshold value of 150 HU (arrowhead) and the level of contrast enhancement (282 HU) at 10 seconds are displayed for the first monitoring scan. Diagnostic image c contains ROIs placed over the main pulmonary artery and the ascending and descending aorta. The bolus-trigger threshold level is typically exceeded during the acquisition of the first monitoring scan at 10 seconds. In some patients, the trigger is delayed, probably because of slow circulation or cardiac output. In a patient with cardiac failure (e), it took 22 seconds to reach a threshold value of 125 HU.

 
As soon as contrast enhancement reached the threshold value (bolus trigger, typically 10 seconds), patients were instructed to hold their breath and were prepared for diagnostic scanning while the CT table moved. This took 5–7 seconds (transit time) depending on the distance needed for the CT table to move from the level of the monitoring scan to the starting level of the diagnostic scan. Finally, the scanning delay for the diagnostic scan was calculated as the sum of the bolus trigger time plus the transit time.

Contrast Enhancement
CT images were retrieved from the institutional picture archiving and communication system and were sent to a clinical workstation (Wizard; Siemens Medical Solutions). The CT images consisted of (a) a single section of an unenhanced image acquired at the level of the main pulmonary artery as a reference image for the bolus-tracking technique, (b) one or more contrast material–enhanced images acquired during bolus-triggered monitoring, and (c) diagnostic contrast-enhanced images obtained craniocaudally from the apex to the base of the thorax.

One author (C.T., with 11 years of experience in interpreting CT images of the chest) measured the mean CT number (in Hounsfield units) of the main pulmonary artery on the unenhanced images and monitoring scans by using a circular ROI cursor, which was chosen to be half the diameter of the vessel (Fig 1). In a similar fashion, mean CT numbers were measured craniocaudally every second in the main pulmonary artery (or in the right ventricle on the sections below the level of the main pulmonary artery) and in the ascending and descending aorta. The size of the ROI for these measurements was chosen to be half of the diameter of the vessel or contrast-enhanced lumen (typical ROI diameter, 7–10 mm).

Contrast enhancement was calculated by subtracting the CT numbers for unenhanced images from those for contrast-enhanced images. Time-averaged contrast enhancement values for the pulmonary artery including right ventricle and those for the aorta were computed for each patient. Scanning delay, scanning duration, and the volume of contrast medium injected were recorded.

Statistical Analysis
Patient data for 16- and 64-section CT were tested for normality by using the Shapiro-Wilk W test and included age, body weight, bolus trigger time, transit time, scanning delay, scanning duration, the volume of contrast medium injected, and the degree of contrast enhancement in the pulmonary artery and aorta. The median and the 95% confidence interval (CI) of the median were calculated. If the data were nonnormally distributed, the 16- and 64-section CT data were tested for statistical significance by using the Wilcoxon signed rank test. For tests of normally distributed data, the equality of variances was tested with the O'Brien, Brown-Forsythe, Levene, and Bartlett tests. Depending on the results of these tests, a t test for either equal or unequal variance was used.

To evaluate the amount of contrast medium injected relative to the patient's body weight, we introduced and calculated the injected contrast material volume per body weight index, measured in milliliters per kilogram body weight, for each patient. Linear regression analyses were performed to investigate the relationship between the contrast material volume per body weight index and the magnitude of mean contrast enhancement of the pulmonary artery and aorta. Because contrast enhancement should be zero when contrast medium is not given, statistical software was used to constrain the intercepts of the regression lines to zero. The 95% CIs were plotted for the regression lines and were calculated for the slopes of the regression lines. The {alpha} level was set at .05. Statistical analyses were performed with computer software (JMP, version 5, SAS Institute, Cary, NC; and MedCalc, MedCalc, Mariakerke, Belgium).


    RESULTS
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 ADVANCES IN KNOWLEDGE
 References
 
Data Distribution, Age, and Weight
The median and the 95% CI of the median are presented in Table 1. Eleven (61%) of 18 data distributions that are represented in Table 1 were nonnormally distributed (P < .05). Because of this characteristic, the results presented in Table 1 were calculated by using the Wilcoxon rank sum test. Only age, pulmonary artery enhancement, and aortic enhancement involved tests in which both data distributions were normal. Of these three variables, only aortic enhancement showed unequal variance (P = .02 for Levene and Bartlett tests). The results of the t test were as follows: age, P = .24; pulmonary artery enhancement, P = .10; and aortic enhancement, P = .70. These P values are similar to those presented in Table 1.


View this table:
[in this window]
[in a new window]

 
Table 1. Patient Demographics, Scan Data, Injection Data, and Contrast Enhancement in the Pulmonary Artery and Aorta for 16- and 64-Section CT

 
There was no significant difference in age or body weight between patients who underwent 16-section CT and those who underwent 64-section CT (Table 1). A wide range of patient weights (45.3–153.0 kg) and contrast medium volumes (76–125 mL) was observed. Pulmonary CT angiograms from three patients (small, medium, and large body size) are presented in Figure 2 to illustrate the different degrees of contrast enhancement.


Figure 2A
View larger version (62K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 2a: Transverse CT images are shown for patients with three different body sizes in whom different degrees of contrast enhancement were seen in the main pulmonary arteries. (a) A 64-year-old man weighing 51 kg scanned with 16-section CT (pulmonary enhancement, 472 HU; contrast material volume per body weight index, 2.5 mL per kilogram body weight). (b) A 68-year-old woman weighing 78 kg scanned with 16-section CT (pulmonary enhancement, 328 HU; contrast material volume per body weight index, 1.3 mL/kg). (c) A 62-year-old man weighing 104 kg scanned with 64-section CT (pulmonary enhancement, 182 HU; contrast material volume per body weight index, 1.1 mL/kg).

 

Figure 2B
View larger version (84K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 2b: Transverse CT images are shown for patients with three different body sizes in whom different degrees of contrast enhancement were seen in the main pulmonary arteries. (a) A 64-year-old man weighing 51 kg scanned with 16-section CT (pulmonary enhancement, 472 HU; contrast material volume per body weight index, 2.5 mL per kilogram body weight). (b) A 68-year-old woman weighing 78 kg scanned with 16-section CT (pulmonary enhancement, 328 HU; contrast material volume per body weight index, 1.3 mL/kg). (c) A 62-year-old man weighing 104 kg scanned with 64-section CT (pulmonary enhancement, 182 HU; contrast material volume per body weight index, 1.1 mL/kg).

 

Figure 2C
View larger version (82K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 2c: Transverse CT images are shown for patients with three different body sizes in whom different degrees of contrast enhancement were seen in the main pulmonary arteries. (a) A 64-year-old man weighing 51 kg scanned with 16-section CT (pulmonary enhancement, 472 HU; contrast material volume per body weight index, 2.5 mL per kilogram body weight). (b) A 68-year-old woman weighing 78 kg scanned with 16-section CT (pulmonary enhancement, 328 HU; contrast material volume per body weight index, 1.3 mL/kg). (c) A 62-year-old man weighing 104 kg scanned with 64-section CT (pulmonary enhancement, 182 HU; contrast material volume per body weight index, 1.1 mL/kg).

 
Amount of Contrast Medium
Pulmonary artery enhancement and contrast material volume per body weight index are plotted in Figure 3. Regression analysis of the magnitude of pulmonary artery and aortic enhancement versus the contrast material volume per body weight index are summarized in Table 2. Notably, the regression equation (pulmonary artery enhancement [in Hounsfield units] = 211 x contrast material volume per body weight index) indicates that 1.0, 1.2, and 2.0 mL/kg of contrast medium containing 350 mg of iodine per milliliter is required to achieve pulmonary artery enhancement of 211, 250, and 422 HU, respectively (P < .001). The regression slope for 64-section CT (y = 221x) was slightly greater than the regression slope for 16-section CT (y = 206x), but the 95% CIs overlapped.


Figure 3
View larger version (22K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 3: Plot of contrast enhancement in the pulmonary artery against injected contrast material volume per body weight index (CVBWI). For the regression, the intercept was constrained to zero: y = 206x  for 16-section CT ({circ}) and y = 221x  for 64-section CT ({triangleup}) (P < .001). Ninety-five percent CIs were fitted to the regression lines. There was a strong trend for contrast enhancement to increase proportionally with the contrast material volume per body weight index.

 

View this table:
[in this window]
[in a new window]

 
Table 2. Regression Results for the Effect of Pulmonary Artery and Aortic Enhancement on the Contrast Material Volume per Body Weight Index for 16- and 64-Section CT

 
Scanning Duration and Pulmonary Artery Enhancement
The median scanning duration for 64-section CT was significantly shorter than the median scanning duration for 16-section CT (5.7 seconds [95% CI: 4.8, 6.0] vs 9.5 seconds [95% CI: 8.4, 9.9], P < .001). Consequently, the amount of contrast medium used during 64-section CT was 17.6% less than the amount of contrast medium used during 16-section CT (85.4 mL [95% CI: 83.2, 88.2] vs 103.6 mL [95% CI: 99.8, 109.7], P < .001). Mean contrast enhancement in the main pulmonary artery including right ventricle was 8.9% lower for 64-section CT than for 16-section CT (257.7 HU [95% CI: 224.8, 293.0] vs 282.9 HU [95% CI: 255.5, 323.4]), but this difference was not statistically significant (P = .11).

A total of five patients (all of whom underwent 16-section CT) received the maximum volume of contrast medium (125 mL). Two of these patients required long scanning durations (16.0 and 16.9 seconds, the two longest scanning durations in the 16-section CT group), and the remaining three patients required long scanning delays (21.0, 22.1, and 28.2 seconds). If more than 125 mL of contrast medium had been allowed to be administered to these patients for the entire duration of 16-section CT, the amount of contrast medium would have been 133–165 mL (calculated as a product of the injection rates multiplied by the sum of scanning delays plus scanning durations).

Trigger Times
Despite the use of a slightly lower bolus-tracking threshold for 16-section CT (100 or 125 HU) compared with 64-section CT (150 HU), the median bolus trigger times were the same (10.0 seconds [95% CI: 10.0, 10.0]), with no statistically significant difference between 16-section CT and 64-section CT (P = .37). This may be because there were more patients in the 16-section CT group (n = 5) than in the 64-section CT group (n = 2) whose bolus trigger time was 15 seconds or more.

In addition, we observed that the transit time from the bolus trigger to the initiation of diagnostic scanning was longer for 16-section CT than for 64-section CT (6.1 seconds [95% CI: 6.1, 6.2] vs 5.6 seconds [95% CI: 5.5, 5.6], P < .001); this was probably because of the older technology of the 16-section CT scanner. As a result of the longer bolus trigger times and longer transit times, the median scanning delay for 16-section CT was longer than the median scanning delay for 64-section CT (16.2 seconds [95% CI: 16.1, 16.3] vs 15.6 seconds [95% CI: 15.6, 15.7], P < .001).

Aortic Enhancement
No significant differences in median aortic enhancement were observed between 16-section CT and 64-section CT (200.4 HU [95% CI: 178.3, 251.1] vs 216.8 HU [95% CI: 177.5, 233.5], P = .91). The regression slope for aortic enhancement for 16- and 64-section CT combined (y = 156x) indicated that 1.0 and 2.0 mL/kg of contrast medium containing 350 mg of iodine per milliliter was required to achieve aortic enhancement of 156 and 312 HU, respectively (P < .001) (Table 2). Similar to the regression slope for pulmonary artery enhancement, the regression slope for aortic enhancement in the 64-section CT group (y = 173x) was slightly greater than the regression slope in the 16-section CT group (y = 147x), but the 95% CIs overlapped (Table 2).


    DISCUSSION
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 ADVANCES IN KNOWLEDGE
 References
 
Our results demonstrate that patient body weight and scanning duration critically affect the degree of contrast enhancement seen during multidetector CT angiography of the pulmonary arteries. To yield a contrast enhancement of 250 HU in the pulmonary artery, the required volume of contrast medium containing 350 mg of iodine per milliliter was calculated to be approximately 1.2 mL/kg injected at a rate of 4 mL/sec (ie, 0.4 g of iodine per kilogram body weight injected at a rate of 1.4 g of iodine per second). Combined with the baseline attenuation value of the unenhanced blood, this degree of contrast enhancement corresponds to a net pulmonary artery attenuation of 280–310 HU. Although, to our knowledge, no one has reported the minimum degree of pulmonary artery enhancement that is required for assessing the diagnosis of pulmonary emboli, contrast enhancement of 250 HU seems adequate in our clinical experience.

The regression slope for pulmonary artery enhancement for 64-section CT was slightly greater than that for 16-section CT. Although this slope difference was not statistically significant, it suggests that, to achieve an equivalent degree of contrast enhancement in the pulmonary artery, slightly less contrast medium is required with 64-section CT than with 16-section CT. A similar trend was noted for aortic enhancement. Furthermore, because the magnitude of the regression slope for pulmonary artery enhancement was greater than the magnitude of the regression slope for aortic enhancement during 16- and 64-section CT, this indicates that, as part of our study design, the scanning delay was optimized for pulmonary artery enhancement rather than for aortic enhancement.

In our study, we used a fixed injection rate of 4 mL/sec and adjusted the injection duration according to the scanning duration and scanning delay. This approach may not be optimal to account for the many variables involved in contrast enhancement. For instance, because body weight is the most important patient-related factor that affects the magnitude of contrast enhancement (15), a weight-based injection protocol is necessary to achieve a consistent degree of contrast enhancement. Larger patients may require higher iodine loads (ie, higher volumes or longer injections) or higher iodine delivery rates (ie, faster injections or higher iodine concentrations in contrast media) than smaller patients to generate an equivalent degree of contrast enhancement.

Furthermore, it is apparent from our results that slow scanners, such as one-, four-, and eight-section CT scanners, would require larger volumes of contrast medium than 16- or 64-section CT scanners to achieve the same degree of contrast enhancement during pulmonary CT angiography.

The results of our study demonstrate that 64-section CT allowed us to use 17.6% less contrast medium than was used with 16-section CT during pulmonary CT angiography. The degree of contrast enhancement obtained during 64-section CT was 8.9% lower than, but not significantly different from, the degree of contrast enhancement obtained during 16-section CT. The reduction or saving of contrast medium during pulmonary CT angiography that occurs as a result of faster scanning is probably applicable to other applications of CT angiography and arterial phase scanning. The degree of saving in contrast medium may vary, however, depending on the target organ, scanning duration, and protocol requirements.

CT angiography that is performed with longer scanning durations or longer scanning delays may require larger amounts of contrast medium. A reduction in contrast medium that is too aggressive may result in suboptimal or nondiagnostic images. One approach to compensate for the reduction in contrast medium during CT angiography while maintaining the degree of contrast enhancement may be to increase the injection rate (20). Finally, the volume of contrast medium could have been further reduced in our study without compromising the quality of contrast enhancement by stopping the injection a few seconds prior to the completion of CT scanning or by using a saline flush.

Multidetector CT is also well suited for multiphasic imaging of the organs. Scans can be obtained at each phase within a few seconds, thereby allowing for the completion of an entire examination while a substantial amount of contrast medium circulates and remains in the vascular and visceral parenchyma. It may be, however, that the required amount of contrast medium for venous phase scanning may not be reduced as much as for arterial phase scanning because the degree of contrast enhancement during the venous phase highly depends on the total amount of contrast medium deposited and diluted in the systemic pool of venous blood (20,21). For the same reason, the volume of contrast medium necessary to achieve adequate contrast enhancement in the veins of the lower extremities for CT venography should be larger than that for pulmonary artery CT angiography only (4,5).

Because of variations in cardiac output among patients (22), it is critical to individualize the scanning delay for CT angiography. A wide range of scanning delays was observed in our study. In particular, seven patients had bolus trigger times that were 15 seconds or longer, presumably caused by slow circulation or cardiac output (no clinical data were sought to verify this assumption). In these cases, the use of a fixed scanning delay is inappropriate and may result in inadequate contrast enhancement. The scanning delay can be individualized by using a test bolus (23,24) or bolus-tracking software (18,25,26).

In our study, a bolus-tracking method was used to determine the scanning delay for pulmonary CT angiography. Diagnostic CT scanning is triggered when contrast enhancement in the main pulmonary artery reaches a threshold value of 100 or 125 HU for 16-section CT and 150 HU for 64-section CT. We used a slightly higher threshold value for 64-section CT, with the belief that a higher threshold should result in a longer scanning delay, to initiate scanning and thus center the scan during maximal contrast enhancement (18,19). The 150-HU threshold value does not, however, appear to be different from the 100- or 125-HU threshold value for determining the scanning delay. This is probably because, in most cases, the increase in pulmonary artery enhancement from 100–125 to 150 HU is very rapid with the fast injection of contrast medium at 4 mL/sec. This finding might also be compounded by the fact that the transit time for 16-section CT is slower than the transit time for 64-section CT. In addition, in our study, more patients were scanned by using a delayed-bolus trigger with 16-section CT compared with 64-section CT.

There were limitations to our study. First, our study was not designed to test the clinical effect or relevance of the different degrees of contrast enhancement on the sensitivity and specificity of diagnosing pulmonary emboli. No follow-up or further clinical evaluation was performed to investigate whether the absence or presence of pulmonary emboli was associated with the degree of contrast enhancement or scanning delay. The main variables we evaluated were patient body weight, scanning duration, scanning delay, the amount of contrast medium injected, and the magnitude of contrast enhancement. We evaluated these variables to investigate the effects of body weight and scanning duration and the implication of the fast scanning speed of multidetector CT on the efficient use of contrast medium during pulmonary CT angiography.

Second, the maximum volume of contrast medium that was allowed in the current study was 125 mL. Although this artificially limits volume comparisons, only five patients with 16-section CT and no patient with 64-section CT would have needed more than 125 mL of contrast medium. As shown, if more than 125 mL had been administered to these patients for the entire scanning duration, then 16-section CT would have required more contrast medium than did 64-section CT, and this idea supports the reduction of contrast medium with 64-section CT.

Third, contrast enhancement was measured in the main pulmonary artery, right ventricle, and aorta. Contrast enhancement in the pulmonary arteries may differ substantially between central and peripheral arteries. However, the measurement of contrast enhancement in small peripheral pulmonary arteries is technically difficult and highly variable depending on the location of these arteries in the lung.

Fourth, the results of our study are based on comparisons between two patient groups, without accounting for individual patient variations. To reduce interpatient variability, an ideal study design would include evaluation of the same patients who were scanned with 16- and 64-section CT at different times. Because of the relatively new installation of our 64-section CT scanner, only a few patients underwent clinically warranted repeat pulmonary CT angiography with 16- and 64-section CT scanners.

In conclusion, to achieve consistent contrast enhancement during pulmonary CT angiography, the required volume of contrast medium can be adjusted to the patient's body weight, with approximately 1.2 mL/kg, yielding contrast enhancement of 250 HU. For pulmonary angiography, we also observed that, because of its faster scanning speed, 64-section CT seems to yield equivalent contrast enhancement with less contrast medium than is used with 16-section CT.


    ADVANCES IN KNOWLEDGE
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 ADVANCES IN KNOWLEDGE
 References
 


    FOOTNOTES
 

Abbreviations: CI = confidence interval • ROI = region of interest

Author contributions: Guarantors of integrity of entire study, K.T.B., C.T.; study concepts/study design or data acquisition or data analysis/interpretation, all authors; manuscript drafting or manuscript revision for important intellectual content, all authors; manuscript final version approval, all authors; literature research, K.T.B., S.G., C.H., M.M.; clinical studies, K.T.B., C.T., F.Z., T.A.G., M.M.; statistical analysis, K.T.B., C.F.H.; and manuscript editing, K.T.B., C.T., S.G., C.H., F.Z., M.M., C.F.H.


    References
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 ADVANCES IN KNOWLEDGE
 References
 

  1. Raptopoulos V, Boiselle PM. Multi–detector row spiral CT pulmonary angiography: comparison with single–detector row spiral CT. Radiology 2001;221:606–613.[Abstract/Free Full Text]
  2. Schoepf UJ, Holzknecht N, Helmberger TK, et al. Subsegmental pulmonary emboli: improved detection with thin-collimation multi–detector row spiral CT. Radiology 2002;222:483–490.[Abstract/Free Full Text]
  3. Yankelevitz DF, Shaham D, Shah A, Rademacker J, Henschke CI. Optimization of contrast delivery for pulmonary CT angiography. Clin Imaging 1998;22:398–403.[CrossRef][Medline]
  4. Washington L, Gulsun M. CT for thromboembolic disease. Curr Probl Diagn Radiol 2003;32:105–126.[CrossRef][Medline]
  5. Schoepf UJ, Costello P. CT angiography for diagnosis of pulmonary embolism: state of the art. Radiology 2004;230:329–337.[Abstract/Free Full Text]
  6. Qanadli SD, Hajjam ME, Mesurolle B, et al. Pulmonary embolism detection: prospective evaluation of dual-section helical CT versus selective pulmonary arteriography in 157 patients. Radiology 2000;217:447–455.[Abstract/Free Full Text]
  7. Ghaye B, Szapiro D, Mastora I, et al. Peripheral pulmonary arteries: how far in the lung does multi–detector row spiral CT allow analysis? Radiology 2001;219:629–636.
  8. Remy-Jardin M, Tillie-Leblond I, Szapiro D, et al. CT angiography of pulmonary embolism in patients with underlying respiratory disease: impact of multislice CT on image quality and negative predictive value. Eur Radiol 2002;12:1971–1978.[Medline]
  9. Tillie-Leblond I, Mastora I, Radenne F, et al. Risk of pulmonary embolism after a negative spiral CT angiogram in patients with pulmonary disease: 1-year clinical follow-up study. Radiology 2002;223:461–467.[Abstract/Free Full Text]
  10. Dean PB, Violante MR, Mahoney JA. Hepatic CT contrast enhancement: effect of dose, duration of infusion, and time elapsed following infusion. Invest Radiol 1980;15:158–161.[CrossRef][Medline]
  11. Kormano M, Partanen K, Soimakallio S, Kivimaki T. Dynamic contrast enhancement of the upper abdomen: effect of contrast medium and body weight. Invest Radiol 1983;18:364–367.[Medline]
  12. Berland LL, Lee JY. Comparison of contrast media injection rates and volumes for hepatic dynamic incremented computed tomography. Invest Radiol 1988;23:918–922.[CrossRef][Medline]
  13. Chambers TP, Baron RL, Lush RM. Hepatic CT enhancement. I. Alterations in the volume of contrast material within the same patients. Radiology 1994;193:513–517.
  14. Small WC, Nelson RC, Bernardino ME, Brummer LT. Contrast-enhanced spiral CT of the liver: effect of different amounts and injection rates of contrast material on early contrast enhancement. AJR Am J Roentgenol 1994;163:87–92.[Abstract/Free Full Text]
  15. Heiken JP, Brink JA, McClennan BL, Sagel SS, Crowe TM, Gaines MV. Dynamic incremental CT: effect of volume and concentration of contrast material and patient weight on hepatic enhancement. Radiology 1995;195:353–357.[Abstract/Free Full Text]
  16. Platt JF, Reige KA, Ellis JH. Aortic enhancement during abdominal CT angiography: correlation with test injections, flow rates, and patient demographics. AJR Am J Roentgenol 1999;172:53–56.[Abstract/Free Full Text]
  17. Bae KT. Technical aspects of contrast delivery in advanced CT. Appl Radiol 2003;32:12–19.
  18. Cademartiri F, Nieman K, van der Lugt A, et al. Intravenous contrast material administration at 16–detector row helical CT coronary angiography: test bolus versus bolus-tracking technique. Radiology 2004;233:817–823.[Abstract/Free Full Text]
  19. Bae KT. Test-bolus versus bolus-tracking techniques for CT angiographic timing [reply]. Radiology 2005;236:369–370.[Free Full Text]
  20. Bae KT, Heiken JP, Brink JA. Aortic and hepatic peak enhancement at CT: effect of contrast medium injection rate—pharmacokinetic analysis and experimental porcine model. Radiology 1998;206:455–464.[Abstract/Free Full Text]
  21. Bae KT. Peak contrast enhancement in CT and MR angiography: when does it occur and why? pharmacokinetic study in a porcine model. Radiology 2003;227:809–816.[Abstract/Free Full Text]
  22. Bae KT, Heiken JP, Brink JA. Aortic and hepatic contrast medium enhancement at CT. II. Effect of reduced cardiac output in a porcine model. Radiology 1998;207:657–662.
  23. van Hoe L, Marchal G, Baert AL, Gryspeerdt S, Mertens L. Determination of scan delay time in spiral CT-angiography: utility of a test bolus injection. J Comput Assist Tomogr 1995;19:216–220.[Medline]
  24. Hittmair K, Fleischmann D. Accuracy of predicting and controlling time-dependent aortic enhancement from a test bolus injection. J Comput Assist Tomogr 2001;25:287–294.[CrossRef][Medline]
  25. Silverman PM, Roberts S, Tefft MC, et al. Helical CT of the liver: clinical application of an automated computer technique, SmartPrep, for obtaining images with optimal contrast enhancement. AJR Am J Roentgenol 1995;165:73–78.[Abstract/Free Full Text]
  26. Birnbaum BA, Jacobs JE, Langlotz CP, Ramchandani P. Assessment of a bolus-tracking technique in helical renal CT to optimize nephrographic phase imaging. Radiology 1999;211:87–94.[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
Am. J. Roentgenol.Home page
D. Roggenland, S. A. Peters, S. P. Lemburg, T. Holland-Letz, V. Nicolas, and C. M. Heyer
CT Angiography in Suspected Pulmonary Embolism: Impact of Patient Characteristics and Different Venous Lines on Vessel Enhancement and Image Quality
Am. J. Roentgenol., June 1, 2008; 190(6): W351 - W359.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
K. T. Bae, B. A. Seeck, C. F. Hildebolt, C. Tao, F. Zhu, M. Kanematsu, and P. K. Woodard
Contrast Enhancement in Cardiovascular MDCT: Effect of Body Weight, Height, Body Surface Area, Body Mass Index, and Obesity
Am. J. Roentgenol., March 1, 2008; 190(3): 777 - 784.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Figures Only
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bae, K. T.
Right arrow Articles by Hildebolt, C. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bae, K. T.
Right arrow Articles by Hildebolt, C. F.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
RADIOLOGY RADIOGRAPHICS RSNA JOURNALS ONLINE